AstraZeneca to pay $5.52 million to resolve SEC foreign bribery case

BY Reuters |

U.S. regulators said on Tuesday that AstraZeneca will pay $5.52 million to resolve a foreign bribery probe into improper payments by its sales and marketing staff to state-employed healthcare…